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Available online 11 November 2016Background:High levels of anxiety are associatedwith worse outcomes in coronary artery disease patients. Little
is known about anxiety levels in patients undergoing coronary procedures. Our objective is to examine the levels
of anxiety in patients undergoing coronary angiography (CAG) or percutaneous coronary intervention (PCI)
during the different phases of hospital stay and to evaluate which patient characteristics are associated with
increased anxiety.
Methods: Patients undergoing CAG or PCI between April 2009 and April 2010 were included in this prospective
cohort study. Anxiety levelsweremeasured using the self reported Visual Analogue Scale (VAS) of Anxiety, rang-
ing from 0 to 100. VAS anxiety scores were obtained at hospital intake, pre- and post-procedure, and at hospital
discharge.
Multivariate linear regression analyses were performed to assess correlations between baseline characteristics
and anxiety levels at the different time points.
Results: In total 2604 patients were included, with 70.4%male participantswith amean age of 65±12 years. VAS
anxiety scoreswere highest pre-procedure (44.2±27.0mm). Female patients reported a signiﬁcantly higher pre
procedure VAS anxiety score (50.4 ± 26.5) compared to males (41.5 ± 26.8, p = 0.02). Other factors associated
with higher levels of anxiety at different time points were age b 65 years, low level of education and an acute
primary PCI.
Conclusion: In the largest cohort to date, we examined anxiety among patients undergoing PCI or CAG was
highest immediately around the procedure, particularly in patients aged b65 years, of female gender, undergoing
primary PCI, or with a lower level of education. Better pre-procedural information or pharmacological strategies
may reduce anxiety in these patients.
© 2016 Elsevier Ireland Ltd. All rights reserved.Keywords:
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High levels of anxiety are associated with worse outcomes in coro-
nary artery disease patients [1,2]. Anxiety is described as a condition
in which a person experiences a sensation of apprehension, along
with activation of the autonomous nervous system, in response to a
vague and unspeciﬁedmenace [3]. High levels of anxiety are associated
with lowered immune response and alterations of cardiovascular
function like impaired heart rate variety, endothelial dysfunction and
vascular inﬂammation, which might result in worse clinical outcomestment of Cardiology, Academic
ef 9, 1105AZ Amsterdam, The
ques).
.[4–6]. Therefore, strategies aiming to minimize anxiety in patients un-
dergoing diagnostic coronary angiography (CAG) and percutaneous
coronary interventions (PCI) are not only important for patient comfort
but could potentially improve outcome.
Little is known about the levels of anxiety during the different hospi-
tal phases of patients undergoing CAG/PCI. Also, patient characteristics
associated with increased pre- and post-procedural anxiety levels dur-
ing CAG or PCI have not been studied in a large clinical cohort. Identiﬁ-
cation of such characteristics could aid health care providers in
identifying the patients who are at highest risk for anxiety. It is impor-
tant to create this awareness so that providers are able to prevent or re-
spond to patient's anxiety.
Our objectives are to examine pre andpost-procedural anxiety levels
in patients undergoing CAG or PCI, and to assess the patient and clinical
characteristics that are associated with higher anxiety levels.
Table 1
Clinical characteristics of the study population.
Characteristics
Total n = 2604
Demographics
Age (years) 65 ± 12
Male gender 1832 (70.4%)
Level of education
Low 693 (26.6%)
Intermediate 936 (35.9%)
High 737 (28.3%)
Unknown 238 (9.1%)
Risk factors
Diabetes mellitus 535 (20.5%)
Known hypertension 1223 (59.0%)
Family history of coronary heart disease 1496 (57.5%)
Hypercholesterolemia 1068 (41.0%)
Current cigarette smoking 598 (22.8%)
Urgency and treatment
Elective CAG or PCI 2168 (83.3%)
Primary PCI 435 (16.7%)
CAG 863 (33.1%)
PCI 1497 (57.5%)
Data are number (%)ormean±SDCAG=coronary angiography PCI=percutane-
ous coronary intervention.
Table 2
Prevalence of anxiety.
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This was a prospective cohort study in which all patients who
underwent a CAG or PCI between April 2009 and April 2010 in the
Academic Medical Center (AMC) were included. The AMC is a high
volume tertiary cardiac care centre in Amsterdam, the Netherlands. All
procedural decisions, including device selection and adjunctive
pharmacotherapy, were made at the discretion of the operator. More-
over, all patients were treated with lorazepam 1 mg sublingual as
premedication 30 min prior to CAG or PCI.
2.1. Data collection
Anxiety was measured with the one-item Visual Analogue Scale
for Anxiety (VAS score) [7–9], ranging from 0 (not anxious) to 100
(extremely anxious). Patients completed the VAS anxiety question in
the presence of nurses who were available to assist if necessary.
Anxiety was assessed at 4 speciﬁc moments (see Fig. 1)
1. at hospital intake
2. immediately pre-procedurally in the cathlab
3. one hour post procedure and
4. at hospital discharge at the ward.
At this latter time point, patients were also asked to retrospectively
score the anxiety they had experienced immediately prior to the
procedure to explore the possible occurrence of a response shift [10]
in reported anxiety level since that time.
Baseline patient characteristics, included age, gender, BMI, cardio-
vascular risk factors (diabetes mellitus type, hypertension, family histo-
ry of coronary artery disease, smoking, dyslipidemia) and procedural
characteristics, whichwere extracted from patientmedical ﬁles and en-
tered into an electronic database. The patient self-reported level of edu-
cationwas also recorded and categorized into low (less than 11 years of
education), intermediate (between 12 and 14 years of education) and
high (15 years or more of education). The study protocol was approved
by the Institutional Review Boards of the AMC.
2.2. Statistical analysis
Values are reported as mean± SD for continuous variables or medi-
an (25th to 75th percentile) and frequency for categorical variables. Un-
paired Student's t-test and a Fisher's exact test were used to compare
differences between groups for continuous and categorical variables, re-
spectively per time point. Changes in anxiety from baseline to each
follow-up assessment were tested with paired t-tests.
Multivariate linear regression analyses were performed to assess
correlations between baseline characteristics and anxiety levels at dif-
ferent time points. Variables with a signiﬁcant association in univariate
analyses (p b 0.10) based on beta coefﬁcients derived from the indepen-
dent t-tests), or that were known fromprevious studies to be associated
with anxiety were all entered in a multivariate regression analysis to
assess factors associated with higher anxiety levels. All statistical tests
were two-tailed, and a value of p b 0.05 was considered statisticallyFig. 1. Timeline of Visual Analogue Scale anxiety score assessment.signiﬁcant. Calculations were generated by SPSS software (version
21.0 for Windows, SPSS, Inc., Chicago, Illinois).3. Results
All included patients (N=2604)were treatedwith a CAG or PCI and
provided informed consent. Mean age of the participants was 65 ±
12 years, participants were predominantly male (70.4%). A total of 598
(22.8%) of the study population were currently smoking and 57.5%
had a family history of coronary heart disease. The majority of the
participants were treated with PCI (57.5%). Table 1 shows the clinical
characteristics of the study population.
At hospital intake the mean VAS anxiety score for the overall study
population was 40.6 ± 25.7. Mean pre procedural VAS anxiety score
was 43.9 ± 26.8 and signiﬁcantly declined post procedure to 25.8 ±
25.6 (p b 0.001). The VAS anxiety score at hospital discharge was
19.5 ± 21.7. After the procedure, patients reported to have experienced
more anxiety prior to the procedure than they reported at that time,
(possible response shift), (46.1 ± 32.9.) (p b 0.001) (see Table 2 and
Fig. 2A). This was the case for both females and men.
Females reported a signiﬁcantly higher VAS anxiety score pre-
procedure (50.4 ± 26.5) compared to the male study population
(41.5 ± 26.8, p = 0.02). These levels of anxiety remained signiﬁcantly
higher across the subsequent time points (see Fig. 2B).
Patients undergoing CAG or PCI reported comparable anxiety
levels (see Fig. 2C). However, patients undergoing a primary PCIVAS
VAS intake 40.8 ± 25.8
VAS pre procedure 44.2 ± 27.0
VAS post procedure 25.6 ± 24.8
VAS at discharge 19.6 ± 22.0
VAS retrospective 45.8 ± 28.7
Mean ± SD. VAS = Visual Analogue Scale. VAS anxiety scores of the study
population at the four different time points. Different time points being at
hospital intake, pre-procedure at the catheterization room, post-procedure
at the catheterization room and during hospital discharge. Also, at discharge
patients were asked to state the anxiety they experienced before the proce-
dure, which is described at VAS retrospective.
Fig. 2.Visual Analogue Scale anxiety score. VAS=Visual Analogue Scale, CAG=coronary angiography, PCI=percutaneous coronary intervention, pPCI=primary percutaneous coronary
intervention. VAS anxiety scores (in mm) of (A) the total study population and VAS anxiety scores categorized per (B) sex, (C) type of intervention, (D) urgency and (E) age at the four
different time points around the CAG or PCI procedure. Different time points being at hospital intake, pre-procedure at the catheterization room, post-procedure at the catheterization
room and during hospital discharge.
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pre-procedure (51.5 ± 28.0 compared to 42.7 ± 26.5 p b 0.001) (see
Fig. 2D).
Patients b65 years had higher anxiety scores prior to the procedure
in comparison to patients with higher age (46.7 ± 27.1 compared to
41.5±26.6 p b 0.001), a difference that disappeared after the procedure
(see Fig. 2E).Patients with a low level of education reported higher post proce-
dural VAS anxiety scores (26.5 ± 25.6) than patients who were inter-
mediately (23.9 ± 23.8, p = 0.01) or highly educated (25.1 ± 24.0,
p = 0.007). Similar results were obtained for the VAS anxiety scores
at discharge (see Fig. 3).
In multivariate analysis, patients with younger age (B = −0.38,
SE = 0.05, p b 0.001) and of female gender (B = 10.2, SE = 1.2, p =
Fig. 3. Level of education and mean anxiety. VAS anxiety scores (in mm) and p-values of low educated (b11 years of education), intermediate educated (12–14 years of education) and
high educated (N14 years of education) patients.
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gency of the PCI. This effect was consistent for anxiety levels measured
at different time points.
4. Discussion
This is the largest cohort investigating anxiety levels of patients un-
dergoing coronary procedures. We found that patients undergoing PCI
or CAG have the highest anxiety level prior to the procedure and that
this anxiety signiﬁcantly declines after the procedure, with a lowest
anxiety level at hospital discharge. Females, younger patients, patients
undergoing primary PCI and patients with a low level of education
reported the highest anxiety levels.
Anxiety and depression are common in patients with established
coronary artery disease (CAD) [11], with prevalence rates ranging
from 20 to 50% for anxiety [12,13] and 30 to 60% for depression [14,
15], respectively. Recent evidence suggests worse cardiac outcomes
are correlated to higher levels of anxiety around the CAG or PCI
procedure [5,16,17].
Whether the relation between anxiety and clinical outcome is
causal is currently unknown but anxiety does have direct effects on car-
diovascular physiology. Anxiety leads to activation of the sympathetic
nervous system. Both central and local myocardial levels of adrenalin
and noradrenalin rise, leading to increased heart rate, changes in
vascular tone and increased susceptibility for rhythm disturbances.
Catecholamin excess in some instances can even lead to severe stress
cardiomyopathy as witnessed in Takotsubo's syndrome. Therefore,
anxiety in patients undergoing cardiac catheterization should not be
neglected and identiﬁcation of factors associatedwith increased anxiety
could aid in further improvement of clinical care as well as outcome for
this group of patients.
We found a clear relation between anxiety levels and the phase of
the procedure, showing highest levels directly prior to the procedureand a sharp decline towards the moment of hospital discharge. These
ﬁndings corroborate data from Trotter et al. that showed that 100 pa-
tients undergoing PCI reported highest anxiety scores pre-procedure
while these scores decreased over time post-procedurally. In the
same study, pre-procedural anxiety was also associated with post-
procedural anxiety at 1 week, underlining the importance of attempts
to decrease pre-procedural anxiety [18]. The decrease in anxiety levels
after CAG and PCI indicates that the procedure itself is the biggest stress-
or, as expected. To our surprise, none of the traditional cardiovascular
risk factors, such as diabetes mellitus type 2 were associated with
more anxiety.
Previous studies demonstrated that in patients undergoing angiog-
raphy, the most fearful aspects of the procedure are (in rank order),
fears of coronary artery bypass surgery, uncertainty about the illness,
death, pain, unfavorable clinical ﬁndings and lying ﬂat in bed [19].
In a study of 831 patients in Sweden on a waiting list for angiogra-
phy, angioplasty, or coronary artery bypass graphy, 6% of patients re-
ported that the most distressing symptom was fear and 43% reported
uncertainty about the future [20]. This uncertainty focused on concerns,
eg, whether they would receive treatment in time (as median waiting
time was ﬁve to eight months), their ﬁnancial situation, and future of
their families.
Pedersen et al. assessed the course of anxiety symptoms over an 18-
month period in patients post PCI in 486 patients. They found that low
education level was associated with more anxiety [21]. In our study,
post procedure VAS anxiety scores were also higher for poorly educated
patients compared to both intermediately and highly educated patients.
However, in multivariate analysis, education level disappeared and fe-
males and younger patients were the only factors associated with
more anxiety. Whether improved instructions, pre-medication and
pre-procedural oral andwritten consent can relieve anxiety, speciﬁcally
in this group of patients, remains to be determined. Other interventions
to reduce anxiety levels such as music during the procedure or an
930 R. Delewi et al. / International Journal of Cardiology 228 (2017) 926–930informative video beforehand could be considered as an alternative [22,
23]. These strategies should perhaps be aimed and adjusted for the pa-
tient groups who are at highest risk so that a tailor-made approach can
be adapted to complement patient education in future regular cardiac
care.
5. Conclusion
Patients undergoing cardiac catheterization experience the highest
levels of anxiety just before the procedure. The highest anxiety levels
are speciﬁcally witnessed in female patients, patients of younger age,
during primary PCI and in patients with a low level of education. Care-
givers should be aware of this heightened anxiety when treating these
patients and programs need to be developed aiming to minimize
anxiety. The effect of such measures on the level of anxiety, but also
on clinical outcome should be addressed in randomized trials.
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